Technical Analysis for OBLN - Obalon Therapeutics, Inc.

Grade Last Price % Change Price Change
D 4.0 0.76% 0.03
OBLN closed up 0.76 percent on Wednesday, February 24, 2021, on 7 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Down
Historical OBLN trend table...

Date Alert Name Type % Chg
Bullish Engulfing Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Doji - Bullish? Reversal 0.76%
Gapped Down Weakness 0.76%
Lower Bollinger Band Touch Weakness 0.76%
Oversold Stochastic Weakness 0.76%
20 DMA Resistance Bearish -8.05%
Wide Bands Range Expansion -8.05%
Up 3 Days in a Row Strength -8.05%
Older End-of-Day Signals for OBLN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 14 hours ago
60 Minute Opening Range Breakout about 19 hours ago
Rose Above Previous Day's High about 19 hours ago
Up 5% about 19 hours ago
Up 3% about 20 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Obalon Therapeutics, Inc. Description

Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. The Obalon balloon system is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed. The Obalon balloon system intends to provide patients and physicians with a reversible and repeatable weight loss solution in an outpatient setting, without altering patient anatomy or requiring surgery. The Company has received Premarket approval (PMA) for its Obalon balloon system based on the results of its United States pivotal clinical trial, referred to as the SMART trial.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Surgery Obesity Anatomy Manufactured Goods Weight Loss Pivotal Behavior Modification Bariatrics Gastric Balloon Toy Balloon

Is OBLN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 10.77
52 Week Low 0.623
Average Volume 11,659,474
200-Day Moving Average 1.46
50-Day Moving Average 3.17
20-Day Moving Average 4.48
10-Day Moving Average 4.43
Average True Range 0.67
ADX 56.0
+DI 31.47
-DI 16.34
Chandelier Exit (Long, 3 ATRs ) 4.00
Chandelier Exit (Short, 3 ATRs ) 5.58
Upper Bollinger Band 5.10
Lower Bollinger Band 3.85
Percent B (%b) 0.12
BandWidth 27.90
MACD Line 0.22
MACD Signal Line 0.41
MACD Histogram -0.1816
Fundamentals Value
Market Cap 31.08 Million
Num Shares 7.77 Million
EPS -13.27
Price-to-Earnings (P/E) Ratio -0.30
Price-to-Sales 3.17
Price-to-Book 1.25
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.48
Resistance 3 (R3) 4.52 4.41 4.40
Resistance 2 (R2) 4.41 4.28 4.39 4.37
Resistance 1 (R1) 4.20 4.21 4.31 4.16 4.35
Pivot Point 4.09 4.09 4.14 4.07 4.09
Support 1 (S1) 3.88 3.96 3.99 3.84 3.65
Support 2 (S2) 3.77 3.89 3.75 3.63
Support 3 (S3) 3.56 3.77 3.60
Support 4 (S4) 3.52